Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Rang in aandelen
#4620
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Aandeelprijs
$3.20
Marktkapitalisatie
$3.24B
Verandering (1 dag)
-2.37%
Verandering (1 jaar)
-11.64%
Land
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Categorie
Healthcare
Koersgeschiedenis voor Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Hoogste slotkoers: $3.15 op 2026-10-01
Laagste slotkoers: $0.24 op 2008-07-01
Laagste slotkoers: $0.24 op 2008-07-01
Koersgeschiedenis van Jiangsu Nhwa Pharmaceutical Co., Ltd. van 2008 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -7.86% |
| 2025 | 0.84% |
| 2024 | -6.47% |
| 2023 | 21.41% |
| 2022 | 29.91% |
| 2021 | -10.52% |
| 2020 | 65.99% |
| 2019 | 11.29% |
| 2018 | -34.33% |
| 2017 | 17.11% |
| 2016 | -13.62% |
| 2015 | 27.78% |
| 2014 | 21.35% |
| 2013 | 73.55% |
| 2012 | 33.53% |
| 2011 | -15.50% |
| 2010 | 63.69% |
| 2009 | 105.21% |
| 2008 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
